Boeing on Saturday warned employees involved in its Space Launch System moon rocket program that it expected to lay off around 400 people. The news comes amid delays and rising costs for NASA’s ...

The news comes amid delays and rising costs for NASA’s Artemis program, which was established during President Trump’s first term, and aims to send astronauts back to the moon. Its budget is ...

The trial initially assessed once-weekly prophylaxis treatment (regular treatment to prevent prolonged and spontaneous bleeding) with investig Bagsværd, Denmark, 5 February 2025 – Novo Nordisk ...

told the meeting that the promising results justify further research and a larger phase 2 trial is planned for the second half of this year, with results expected in around 2026. Novo Nordisk’s ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... s stock declined approximately 20% following clinical trial results for its obesity drug, CagriSema.

In this video, I will go over Novo Nordisk's (NVO-3.62%) and Eli Lilly's recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Novo Nordisk itself has a new and improved drug under development. Amycretin saw some participants lose 22% of their body weight in an early trial, though it is some years from being ready for the ...

Novo Nordisk is also developing an oral drug for obesity, amycretin, which also performed better than Wegovy in a phase 3 obesity trial and is in mid-stage development. New approval for Zepbound ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...